dm+d
443374004
Medicine Compliance Aid Stability
SycrestOrganon Pharma Ltd
Organon Pharma Ltd
Sycrest
Tablets sublingual 5mg, 10mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Sublingual tablets - protect from light and moisture
25 October 2022
Lactation Safety Information
Carbamazepine; Appropriate second generation antipsychotic
No published evidence of safety
Long half-life increases risk of accumulation in breastfed infants
Low levels anticipated in milk due to low oral bioavailability and high protein binding
3 January 2018